About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Hepatobiliary and Pancreatic Diseases International
›
top-articles
Hepatobiliary and Pancreatic Diseases International
1.5
(top 50%)
impact factor
2.3K
(top 10%)
papers
26.6K
(top 10%)
citations
51
(top 10%)
h
-index
1.6
(top 50%)
impact factor
2.7K
all documents
28.1K
doc citations
71
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
Hepatobiliary and Pancreatic Diseases International
2017
386
2
Hepatocellular carcinoma: current management and recent advances
Hepatobiliary and Pancreatic Diseases International
2008
302
3
Inflammatory response of macrophages in infection
Hepatobiliary and Pancreatic Diseases International
2014
146
4
Detection of tumor stem cell markers in pancreatic carcinoma cell lines
Hepatobiliary and Pancreatic Diseases International
2007
140
5
Severe acute pancreatitis: pathogenesis, diagnosis and surgical management
Hepatobiliary and Pancreatic Diseases International
2017
109
6
Primary graft dysfunction after liver transplantation
Hepatobiliary and Pancreatic Diseases International
2014
106
7
Changes of gut bacteria and immune parameters in liver transplant recipients
Hepatobiliary and Pancreatic Diseases International
2012
105
8
Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
Hepatobiliary and Pancreatic Diseases International
2018
104
9
Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway
Hepatobiliary and Pancreatic Diseases International
2019
104
10
Interleukin-6: a villain in the drama of pancreatic cancer development and progression
Hepatobiliary and Pancreatic Diseases International
2014
92
11
Pathophysiological consequences of obstructive jaundice and perioperative management
Hepatobiliary and Pancreatic Diseases International
2018
91
12
Pathogenesis and treatment of parenteral nutrition-associated liver disease
Hepatobiliary and Pancreatic Diseases International
2012
90
13
Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma
Hepatobiliary and Pancreatic Diseases International
2005
89
14
Hepatocyte differentiation of mesenchymal stem cells
Hepatobiliary and Pancreatic Diseases International
2012
88
15
Predictive value of C-reactive protein/albumin ratio in acute pancreatitis
Hepatobiliary and Pancreatic Diseases International
2017
86
16
Efficacy of intramuscular matrine in the treatment of chronic hepatitis B
Hepatobiliary and Pancreatic Diseases International
2004
85
17
Augmented reality technology for preoperative planning and intraoperative navigation during hepatobiliary surgery: A review of current methods
Hepatobiliary and Pancreatic Diseases International
2018
84
18
Bedside index for severity in acute pancreatitis: comparison with other scoring systems in predicting severity and organ failure
Hepatobiliary and Pancreatic Diseases International
2013
76
19
Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice
Hepatobiliary and Pancreatic Diseases International
2004
70
20
Portal vein thrombosis
Hepatobiliary and Pancreatic Diseases International
2005
69
21
Endobiliary radiofrequency ablation for malignant biliary obstruction
Hepatobiliary and Pancreatic Diseases International
2013
67
22
Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution's experience with 398 consecutive patients
Hepatobiliary and Pancreatic Diseases International
2014
66
23
Classification of iatrogenic bile duct injury
Hepatobiliary and Pancreatic Diseases International
2007
66
24
Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance
Hepatobiliary and Pancreatic Diseases International
2017
65
25
Obesity, fatty liver and liver cancer
Hepatobiliary and Pancreatic Diseases International
2005
65
26
Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases
Hepatobiliary and Pancreatic Diseases International
2010
65
27
Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury
Hepatobiliary and Pancreatic Diseases International
2005
64
28
Specific molecular markers in hepatocellular carcinoma
Hepatobiliary and Pancreatic Diseases International
2007
63
29
APACHE system is better than Ranson system in the prediction of severity of acute pancreatitis
Hepatobiliary and Pancreatic Diseases International
2006
62
30
Gut microbiota and non-alcoholic fatty liver disease
Hepatobiliary and Pancreatic Diseases International
2015
61
31
Advances in preoperative assessment of liver function
Hepatobiliary and Pancreatic Diseases International
2014
60
32
Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression
Hepatobiliary and Pancreatic Diseases International
2013
59
33
Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases
Hepatobiliary and Pancreatic Diseases International
2014
59
34
Chimeric antigen receptor-engineered T-cell therapy for liver cancer
Hepatobiliary and Pancreatic Diseases International
2018
59
35
Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
Hepatobiliary and Pancreatic Diseases International
2004
59
36
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma
Hepatobiliary and Pancreatic Diseases International
2007
59
37
Risk factors for early recurrence of small hepatocellular carcinoma after curative resection
Hepatobiliary and Pancreatic Diseases International
2010
59
38
High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancer
Hepatobiliary and Pancreatic Diseases International
2012
58
39
The International Study Group of Pancreatic Surgery definition of delayed gastric emptying and the effects of various surgical modifications on the occurrence of delayed gastric emptying after pancreatoduodenectomy
Hepatobiliary and Pancreatic Diseases International
2017
58
40
Recurrence and metastasis of hepatocellular carcinoma: progress and prospects
Hepatobiliary and Pancreatic Diseases International
2002
58
41
Surgical treatment of xanthogranulomatous cholecystitis: experience in 33 cases
Hepatobiliary and Pancreatic Diseases International
2007
58
42
Diagnosis and treatment of polypoid lesions of the gallbladder: report of 194 cases
Hepatobiliary and Pancreatic Diseases International
2004
57
43
Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts
Hepatobiliary and Pancreatic Diseases International
2012
56
44
Neural invasion in pancreatic carcinoma
Hepatobiliary and Pancreatic Diseases International
2002
56
45
Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model
Hepatobiliary and Pancreatic Diseases International
2008
56
46
Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis
Hepatobiliary and Pancreatic Diseases International
2009
56
47
Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathway
Hepatobiliary and Pancreatic Diseases International
2011
55
48
Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery
Hepatobiliary and Pancreatic Diseases International
2014
55
49
Th1 cytokine-based immunotherapy for cancer
Hepatobiliary and Pancreatic Diseases International
2014
55
50
Role of laparoscopic subtotal cholecystectomy in the treatment of complicated cholecystitis
Hepatobiliary and Pancreatic Diseases International
2006
55
site/software ©
exaly
; All materials licenced under
CC by-SA
.